Litcius/Paper detail

BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma

Ming Zhang, Ganping Wang, Zhikun Ma, Gan Xiong, Wenjin Wang, Zhengxian Huang, Yuehan Wan, Xiuyun Xu, Rosalie G. Hoyle, Yi Chen, Jinsong Hou, Xiqiang Liu, Demeng Chen, Jiong Li, Cheng Wang

2022Molecular Therapy38 citationsDOIOpen Access PDF

Topics & Concepts

MHC class IHead and neck squamous-cell carcinomaHead and neckImmunityBasal cellCancer researchMHC class IIBiologyMajor histocompatibility complexMedicineOncologyHead and neck cancerInternal medicineImmunologyImmune systemCancerSurgeryProtein Degradation and InhibitorsHistone Deacetylase Inhibitors ResearchCAR-T cell therapy research
BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma | Litcius